Generics
Zydus Lifesciences signs licensing and supply agreement with Viwit Pharmaceuticals
16 September 2024 - India-based pharmaceutical company focused on manufacturing generic drugs Zydus Lifesciences Ltd. announced on Friday that its wholly owned subsidiary, Zydus Lifesciences Global FZ...
Hikma Pharmaceuticals extends KLOXXADO nasal spray shelf-life 8mg from 24 to 36 months
16 August 2024 - Hikma Pharmaceuticals PLC, a London-based, multinational pharmaceutical company, announced on Thursday that it has extended the shelf-life of KLOXXADO (naloxone HCl) nasal spray eight...
Sun Pharma's LEQSELVI 8mg tablets receive US FDA approval
29 July 2024 - India-based specialty generics company with a presence in specialty, generics, and consumer healthcare products Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) (Bloomberg: SUNP ...
Emmaus Life Sciences names new chief executive officer
24 July 2024 - Sickle cell disease treatment specialist Emmaus Life Sciences Inc (OTCMarkets: EMMA) announced on Tuesday the appointment of Willis C Lee as its new chief executive officer.Lee was prev...
Sun Pharma finalises Taro acquisition
24 June 2024 - Indian pharmaceutical company Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) (BSE:524715) confirmed on Monday that it has completed its merger with Taro Pharmaceutical Industries...
Sun Pharmaceutical announces results from Phase one, multiple ascending-dose study of GL0034 (Utreglutide) at 84th ADA
24 June 2024 - Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) (Bloomberg: SUNP IN) (NSE: SUNPHARMA) (BSE: 524715), an India-based, global specialty generics company with presence in Innovativ...